Comparison of efficacy and tolerability of iron polymaltose complex with ferrous sulphate in treatment of children with iron deficiency anemia

Saba Bakht; Madeeha Ikram; Syeda Sadaf Shirazi; Osman Bin Saif; Fazal Ur Rehman; Aimen Saif

Abstract
Objective: To compare ferrous sulphate and iron polymaltose complex in terms of mean change in hemoglobin and frequency of complications in treatment of iron deficiency anemia (IDA) in children.
Methodology: This Randomized control trial was done at department of pediatrics KRL hospital Islamabad from June 2017 to November 2017. Children with IDA, 6-12 years of age with hemoglobin level less than 10mg/dl were enrolled and admitted in ward. Two groups were formed; patients in Group A were administered ferrous sulphate and Group B iron polymaltose complex. Patients in each group were supervised with iron 6mg per kg per day, for a period of one month. Blood samples were taken at the start and end of one month of iron therapy completion to measure hemoglobin levels along with the complications.
Results: The study included 148 cases; 74 in each group. Mean age among group A was 8.93+1.93 and for group B was 8.35+1.88 years. Frequency of male and female sample population was 43.24% and 56.76% in Group-A while and 50% and 50% in Group-B. Mean change in hemoglobin was 1.35+0.80 in Group-A and 0.90+1.00 in Group-B, (p=0.003) showing a significant difference in hemoglobin after one month of therapy. Likewise, mean change for ferritin level before and after one month, was 1.62+0.63 in Group-A and 0.82+1.06 in Group-B (p=0.000).
Conclusion: On comparison of ferrous sulphate and iron polymaltose complex in terms of mean change in hemoglobin and frequency of complications in treatment of IDA in children, ferrous sulphate was found to be significantly convalescent than iron polymaltose complex.

Key words: Iron deficiency anemia, ferrous sulphate, iron polymaltose complex, mean change.

ABOUT JOURNAL About Publisher Contact Us Editorial & Peer Review Process	POLICIES Privacy Policy Editorial Policy Author's Rights and Obligations Conflict of Interest Policy Plagiarism Policy Advertising Policy	STATEMENTS Terms of Use Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Protection of Research Participants (Statement On Human And Animal Rights) License Information

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

Indexed in Scopus, Web of Science, WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED and Tehqeeqat

How to cite this article

	Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements